Table 7.
Pharmacokinetic parameters of vilaprisan (VPR) metabolite M-4 (BAY 1139463) in pooled plasma samples of 14 subjects after single oral administration of VPR 4 mg with and without concomitant administration of itraconazole (ITZ) 200 mg/day (drug–drug interaction study)
| Parameter | Unit | VPR | VPR + ITZ |
|---|---|---|---|
| µg·h/L | 18.7 | 409 | |
| AUC0–24 | µg·h/L | 29.6 | 48.7 |
| C max | µg/L | 3.02 | 5.67 |
| t 1/2 | h | 26.4 | 303 |
| t last | h | 12 | 264 |
| t max | h | 2.00 | 2.00 |
AUC0–t area under the concentration–time curve from time zero to time t, Cmax maximum plasma concentration, t1/2 terminal half-life, tlast time of last concentration above lower limit of quantitation, tmax time to reach Cmax
Note: Pooled samples were used for exploratory quantitation of M-4. The extrapolated fraction of the AUC exceeded 50% for both treatments so that AUCs are not provided here